Please login to the form below

Not currently logged in
Email:
Password:

Lucid adds to senior leadership team

Shula Sarner and Tanya Goodyear join the med comms agency

Lucid Shula SarnerLucid Group has expanded its senior leadership team with the appointments of Shula Sarner and Tanya Goodyear.

Sarner (pictured right) becomes executive scientific director at the medical communications agency, bringing 15 years of experience as a medical researcher in both academic and biotech sectors.

Most recently, Sarner served as global scientific strategy director at integrated medhealth communications (imc), leading scientific strategy and business development across teams.

Prior to this, she held a number of increasingly senior scientific strategy roles at US medical communications agency Lockwood, and served as a scientific director for Medicus International.

Lucid Tanya GoodyearMeanwhile, Goodyear (pictured left) joins Lucid as its immunology division director, bringing 16 years of experience in healthcare communications and medical education.

Goodyear moves from inVentiv Medical Communications, which she joined as senior vice president for medical communications in February 2015 before becoming director of commercial strategy at the beginning of this year.

Her previous experience includes serving as head of project management for OnMedica, an online medical resources and education platform for healthcare professionals, and a medical writer for Adelphi Medi Cine, part of Adelphi.

Goodyear said: “Lucid immediately felt like the perfect team for me - the passion, innovation and creativity running through everything Lucid does translates into world-leading medical education programmes that really do change behaviour.”

5th October 2016

From: PME

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Havas Life Medicom

We’re a specialist-led, unified communications agency delivering connected healthcare communications, informed through fresh insights, smart thinking and inspired ideas. Our...

Latest intelligence

Measures for measures
Why pharma’s marketing metrics must close the loop...
Where next in Alzheimer’s disease R&D?
How past failures and emerging biology are reshaping drug development...
Brain scan
Brain power: fresh approaches to Alzheimer’s drug discovery
New alliances are learning from past mistakes and breaking down research barriers...

Infographics